Gerry A Quinn
Overview
Explore the profile of Gerry A Quinn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quinn G, Dyson P
NPJ Antimicrob Resist
. 2025 Jan;
2(1):8.
PMID: 39843508
The discoveries of penicillin and streptomycin were pivotal for infection control with the knowledge subsequently being used to enable the discovery of many other antibiotics currently used in clinical practice....
2.
Dyson P, Banat I, Quinn G
Front Pharmacol
. 2025 Jan;
15():1504901.
PMID: 39840088
The WHO has compiled a list of pathogens that urgently require new antibiotics in response to the rising reports of antibiotic resistance and a diminished supply of new antibiotics. At...
3.
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe
Quinn G, Connolly M, Fenton N, Hatfill S, Hynds P, OhAiseadha C, et al.
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256468
Background: Most government efforts to control the COVID-19 pandemic revolved around non-pharmaceutical interventions (NPIs) and vaccination. However, many respiratory diseases show distinctive seasonal trends. In this manuscript, we examined the...
4.
Martins N, Rodrigues da Silva A, Ratcliffe N, Evangelho V, Castro H, Quinn G
J Med Microbiol
. 2023 Nov;
72(11).
PMID: 37991419
No abstract available.
5.
OhAiseadha C, Quinn G, Connolly R, Wilson A, Connolly M, Soon W, et al.
Int J Environ Res Public Health
. 2023 Apr;
20(7).
PMID: 37047846
Since the start of the COVID-19 pandemic in early 2020, governments around the world have adopted an array of measures intended to control the transmission of the SARS-CoV-2 virus, using...
6.
Saric E, Quinn G, Nalpas N, Paradzik T, Kazazic S, Filic Z, et al.
mSystems
. 2022 Sep;
7(5):e0019922.
PMID: 36094082
Streptomyces rimosus is an industrial streptomycete, best known as a producer of oxytetracycline, one of the most widely used antibiotics. Despite the significant contribution of species to the pharmaceutical industry,...
7.
Bakshi H, Quinn G, Nasef M, Mishra V, Aljabali A, El-Tanani M, et al.
Cells
. 2022 May;
11(9).
PMID: 35563808
Angiogenesis and metastasis play pivotal roles in the progression of cancer. We recently discovered that crocin, a dietary carotenoid derived from the Himalayan crocus, inhibited the growth of colon cancer...
8.
Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon
Bakshi H, Quinn G, Aljabali A, Hakkim F, Farzand R, Nasef M, et al.
Pharmaceuticals (Basel)
. 2021 Dec;
14(12).
PMID: 34959610
The prevalence of colon-associated diseases has increased significantly over the past several decades, as evidenced by accumulated literature on conditions such as Crohn's disease, irritable bowel syndrome, colorectal cancer, and...
9.
Salim Al Zoubi M, Al-Eitan L, Rababah D, Al-Batayneh K, Farzand R, Quinn G, et al.
Exp Oncol
. 2021 Jun;
43(2):149-154.
PMID: 34190511
Background: Genetic predisposition to breast cancer (BC) has been extensively explored to achieve an enhanced understanding of the biology of BC. Targeting candidate genes to screen different genetic variants such...
10.
Quinn G, Banat A, Abdelhameed A, Banat I
J Med Microbiol
. 2020 Jul;
69(8):1040-1048.
PMID: 32692643
Given the increased reporting of multi-resistant bacteria and the shortage of newly approved medicines, researchers have been looking towards extreme and unusual environments as a new source of antibiotics. currently...